Skip to content
2000
Volume 5, Issue 1
  • ISSN: 1570-1646
  • E-ISSN: 1875-6247

Abstract

The advent of the post genomics era coupled with advances in proteomics presents unprecedented opportunities for expedited discovery of microbial targets for subsequent development of novel modalities for management of infectious diseases. Here, we review a new application of proteomics called Proteomics-based Expression Library Screening (PELS). This functional proteomics tool permits rapid definition of comprehensive microbial immunoproteomes (microbial proteins expressed in vivo that elicit and interact with the host humoral immune response), a subset of which have excellent potential as diagnostic, drug and vaccine targets. PELS is a platform technology that is applicable to any sequenced pathogen. It offers several advantages over existing methods for global identification of immunogenic microbial proteins, and is both a rapid alternative and an adjunct to emerging protein antigen array/chip technologies.

Loading

Article metrics loading...

/content/journals/cp/10.2174/157016408783955137
2008-04-01
2025-09-09
Loading full text...

Full text loading...

/content/journals/cp/10.2174/157016408783955137
Loading

  • Article Type:
    Research Article
Keyword(s): diagnostic; drug-target; immunogenic; pathogen specific-markers; Proteomics; vaccine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test